Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 13, 2019 Off

Walgreens Boots Alliance Announces Collaboration for Cancer Prevention, Research and Support

By BusinessWire

Transatlantic Charitable Partnership Aims to Meet the Needs of People Living with Cancer DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq:…

May 13, 2019 Off

ORIC Pharmaceuticals Announces Initiation of Phase 1b Study with ORIC-101 in Patients with Cancer

By BusinessWire

Clinical study to evaluate the potential of ORIC’s novel glucocorticoid receptor antagonist to be used in combination with Abraxane® SOUTH…

May 13, 2019 Off

ICON Awarded Clinical Research Team of the Year and Best in Health Economics and Outcomes Research

By BusinessWire

ICON Wins Multiple Awards at the 2019 Clinical and Research Excellence Awards DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a global provider…

May 13, 2019 Off

AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

By BusinessWire

Regulatory clearances achieved that enable integration of the plato™ platform into Fabry FAB-201 and Gaucher GAU-201 clinical trials in the…

May 13, 2019 Off

AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

By BusinessWire

Regulatory clearances achieved that enable integration of the plato™ platform into Fabry FAB-201 and Gaucher GAU-201 clinical trials in the…

May 13, 2019 Off

AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

By BusinessWire

Regulatory clearances achieved that enable integration of the plato™ platform into Fabry FAB-201 and Gaucher GAU-201 clinical trials in the…

May 13, 2019 Off

Schrödinger to Present at May Conferences

By BusinessWire

NEW YORK–(BUSINESS WIRE)–Schrödinger today announced that the Company will be presenting on its advanced computational platform, which integrates physics-based molecular…

May 13, 2019 Off

Sesen Bio Reports First Quarter 2019 Financial Results and Updated, Preliminary Primary and Additional Secondary Endpoint Data from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer

By BusinessWire

Company Announces Confirmed Meetings with the U.S. Food and Drug Administration in May and June 2019 to Review Registration Strategy…

May 13, 2019 Off

Sesen Bio Reports First Quarter 2019 Financial Results and Updated, Preliminary Primary and Additional Secondary Endpoint Data from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer

By BusinessWire

Company Announces Confirmed Meetings with the U.S. Food and Drug Administration in May and June 2019 to Review Registration Strategy…

May 13, 2019 Off

ElevateBio Launches to Create and Operate a Portfolio of Highly Innovative Cell and Gene Therapy Companies

By BusinessWire

– ElevateBio to leverage its fully integrated, company building bench-to-bedside capabilities exclusively focused on cell and gene therapies – ElevateBio’s…

Posts pagination

Previous 1 … 3,200 3,201 3,202 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine